Skin care therapy company Revance Therapeutics cleans up with $45M financing

Revance Therapeutics Inc. has closed a $45 million round of financing led by Palo Alto-based Essex Woodlands Health Ventures and a new investor, NovaQuest Capital, the company said Friday.